Study of how inflammatory genes work in hidradenitis
Part of Infections, Skin clinical trials.
This study looks at how certain body “inflammatory genes” behave in people with hidradenitis suppurativa. It may help researchers understand what drives this condition and how future treatments could be targeted.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with hidradenitis suppurativa
- You are not pregnant
- This is not for people with mainly cosmetic skin issues (like moles)
- You should not have other inflammatory skin diseases such as psoriasis, rosacea, or atopic dermatitis
- You should not have another inflammatory skin condition besides hidradenitis suppurativa
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how “stress” inside skin cells may be connected to hidradenitis suppurativa, a long-term painful skin condition with recurrent bumps and tunnels. Your participation may help researchers understand what drives the disease.
This study looks at the physical and biological (body-related) characteristics of hidradenitis suppurativa. It may help researchers understand the condition better and improve future care.
This study tracks the daily experiences of people living with hidradenitis suppurativa to learn more about their symptoms and treatment patterns. By participating, you help doctors better understand this condition, which could lead to improved care and support.
This study looks at the underlying causes of hidradenitis suppurativa (HS), a skin condition that causes painful lumps. By joining, you help researchers understand the disease better, which could lead to improved treatments.
This trial tests a new medicine called HB0043 for people with moderate to severe hidradenitis suppurativa (a skin condition causing painful lumps). It aims to see if the drug is safe and helps reduce symptoms.
This study looks at what affects the “path” (trajectory) of long-lasting inflammatory skin conditions. It may help researchers understand why symptoms change and how treatments or factors influence those changes.
Hear when a new Hidradenitis Suppurativa trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.